DeFi derivatives protocol Synthetix is returning to the Ethereum Mainnet after a three-year stint on various Layer-2 networks. The move comes as a response to fragmentedDeFi derivatives protocol Synthetix is returning to the Ethereum Mainnet after a three-year stint on various Layer-2 networks. The move comes as a response to fragmented

Synthetix Ditches Layer-2s, Returns to Ethereum’s Mainnet

2025/12/20 06:16
Okuma süresi: 3 dk

DeFi derivatives protocol Synthetix is returning to the Ethereum Mainnet after a three-year stint on various Layer-2 networks. The move comes as a response to fragmented liquidity that saw its native token, SNX, fall approximately 83% since late 2024. This strategic shift signals renewed confidence in Ethereum’s ability to handle high-speed financial applications, a development that could reshape the DeFi landscape.

Market Cap
24h 7d 30d 1y All Time

Why is Synthetix Leaving Layer-2s?

For years, high transaction fees on Ethereum pushed complex applications like Synthetix to cheaper, faster networks called Layer-2 solutions. Think of these as side roads built to ease traffic on the main highway. Synthetix moved its operations to networks like Optimism, Arbitrum, and Base to keep trading costs low for users.

However, this solution created a new problem: fragmented liquidity. Spreading its operations across multiple networks splits up its user base and capital, making markets less efficient. According to a report from ainvest.com, this fragmentation was a key factor behind the SNX token’s steep decline. In response, Synthetix will phase out its presence on Base, Arbitrum, and Optimism by mid-2025.

DISCOVER: Top 20 Crypto to Buy in 2025 

What Does This Mean for DeFi Investors?

Synthetix’s return is a major vote of confidence in Ethereum. Thanks to ongoing upgrades, Ethereum’s average transaction fee is nearly 26 times lower than it was a year ago. This makes it viable once again for heavy-duty applications like perpetual futures DEXs—platforms for trading crypto derivatives.

Founder Kain Warwick stated that Ethereum is now “the best place to run a perp DEX” because it holds the most liquidity, the lifeblood of any trading platform. Synthetix V3 aims to tap into the estimated $160 billion of stablecoin liquidity on Ethereum that is currently underused in derivatives, as noted by PANews. To consolidate its ecosystem, Synthetix also recently acquired Kwenta, its main trading interface.

DISCOVER: 9+ Best High-Risk, High-Reward Crypto to Buy in 2025 

The reality of Synthetix’s return is that access is currently a gated community. Only the top 500 traders from the V3 competition and a handful of SLP whitelisters can actually deposit. This ‘soft launch’ makes one thing clear: the team cares more about doing things safely than chasing a flashy TVL number.

The Synthetix Liquidity Provider (SLP) vault effectively acts as the house. Traders aren’t trading against each other, but directly against the SLP pool, which collects fees when traders lose and pays out when they win. In exchange for taking the other side of every trade, SLP depositors earn yield but also absorb the risk of skilled traders outperforming the system. This is one reason Synthetix is rolling out version 3 cautiously.

This homecoming could attract significant capital back to Ethereum and intensify competition among DeFi protocols. With a new perpetual DEX launch and a $1 million trading competition on the horizon, Synthetix is positioning itself to reclaim its status as a core DeFi pillar.

The move centralizes liquidity and development on crypto’s most secure and liquid blockchain, potentially setting a trend for other protocols that once fled due to high costs.

DISCOVER: 20+ Next Crypto to Explode in 2025 

The post Synthetix Ditches Layer-2s, Returns to Ethereum’s Mainnet appeared first on 99Bitcoins.

Piyasa Fırsatı
Solayer Logosu
Solayer Fiyatı(LAYER)
$0,08901
$0,08901$0,08901
-0,78%
USD
Solayer (LAYER) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen [email protected] ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Paylaş
BitcoinEthereumNews2025/09/18 06:29
👨🏿‍🚀TechCabal Daily – Locked out of Eden

👨🏿‍🚀TechCabal Daily – Locked out of Eden

In today's edition: Eden Life pauses consumer operations || Eskom gets vote to split || Airtel's Smartcash targets Nigeria's mobile market || Cell C is profitable
Paylaş
Techcabal2026/02/16 14:02
USDC Transfer Stuns Market: $1.12 Billion Binance Exodus to Unknown Wallet Sparks Analysis

USDC Transfer Stuns Market: $1.12 Billion Binance Exodus to Unknown Wallet Sparks Analysis

BitcoinWorld USDC Transfer Stuns Market: $1.12 Billion Binance Exodus to Unknown Wallet Sparks Analysis A seismic shift in digital asset liquidity occurred today
Paylaş
bitcoinworld2026/02/16 14:15